Clinical Trial Update: Mode of Action of Ondansetron, a 5-HT Receptor 3 Antagonist, in Lactulose Induced Diarrhoea [Phase 4]

View source ↗

Summary

Phase 4 trial update examining how ondansetron, a 5-HT3 antagonist, works in lactulose-induced diarrhoea and related intestinal motility issues.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Motility Disorder of the Intestine

Drugs mentioned

• Ondansetron (ondansetron)

Snippet

Sponsor: University of Nottingham | Conditions: Motility Disorder of Intestine, Ondansetron | Phase 4 | Status: COMPLETED